Ultrasound could replace colonoscopies for Crohn's patients on new drug
NCT ID NCT07308067
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 18 times
Summary
This study looks at how fast risankizumab (Skyrizi) heals all layers of the gut in people with Crohn's disease. Instead of repeated colonoscopies, researchers use intestinal ultrasound to check healing at 4 and 12 weeks. About 109 adults starting risankizumab in routine care will take part. The goal is to see if ultrasound can reliably track deep healing, which may lead to better long-term outcomes and fewer hospital visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE (CD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amiens university hospital
Amiens, France
-
Clermont-Ferrand University hospital
Clermont-Ferrand, France
-
Grenoble university hospital
Grenoble, France
-
Marseille University Hospital
Marseille, France
Conditions
Explore the condition pages connected to this study.